Thalidomide: Therapeutic potential in hematologic malignancies

This publication has 14 references indexed in Scilit:

• Thalidomide on the comeback trail
  Nature Medicine, 1999
• Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma
  Blood, 1999
• Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
  Leukemia, 1999
• S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide
  Clinical Therapeutics, 1999
• Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
  British Journal of Cancer, 1999
• Current Drug Therapy for Multiple Myeloma
  Drugs, 1999
• Inhibition of Angiogenesis by Thalidomide Requires Metabolic Activation, Which Is Species-dependent
  Biochemical Pharmacology, 1998
• Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
  Experimental Eye Research, 1997
• Angiogenesis in cancer, vascular, rheumatoid and other disease
  Nature Medicine, 1995
• Bone marrow angiogenesis and progression in multiple myeloma
  British Journal of Haematology, 1994